PhD student position – Functional Genomics and Computational Biology

Organization
University of Erlangen-Nuremberg
Job Location
Germany
Salary
50% E 13 TV-L
Job Description

A three-year Ph.D. position (50% E 13 TV-L) is immediately available at the Department of Biology (http://www.biologie.nat.uni-erlangen.de/English/home.shtml) at the University of Erlangen-Nuremberg (Germany).

The focus of our research group is on understanding the functional aspects of the human genome in health and disease through the analysis of the different levels of information encoded in the sequence. Some of our publications include:
Taher et al., Sequence signatures extracted from proximal promoters can be used to predict distal enhancers, Genome Biology, 2013 (http://www.ncbi.nlm.nih.gov/pubmed/24156763).
R.P. Smith et al., Massively parallel decoding of mammalian regulatory sequences supports a flexible organizational model, Nat Genet, 2013 (http://www.ncbi.nlm.nih.gov/pubmed/23892608).

Requirements

We are looking for talented, highly motivated applicants with:
1. A master’s degree or equivalent within the field of biology, computational biology or related fields.
2. Demonstrated proficiency in at least one common programming language.
3. Strong written and oral communication skills in English.

How to Apply

Please email applications to Leila Taher ([email protected]) with the subject "PhD Position" until April 15th, 2015. An application package must contain the following documents in English (please, all in one PDF file):
1. A letter of interest.
2. A complete curriculum vitae.
3. Copies of transcripts
4. Names and contact information for 2-4 references.

A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.